Granahan Investment Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$3,140,000
+13.4%
348,473
+50.6%
0.06%
+15.4%
Q2 2021$2,769,000
+1.2%
231,344
+5.9%
0.05%
-10.3%
Q1 2021$2,737,000
-32.0%
218,468
-15.3%
0.06%
-35.6%
Q4 2020$4,026,000
+275.6%
257,976
+127.5%
0.09%
+150.0%
Q3 2020$1,072,000
-3.5%
113,388
-8.5%
0.04%
-10.0%
Q2 2020$1,111,000
+72.5%
123,951
+22.6%
0.04%
+14.3%
Q1 2020$644,000
-25.0%
101,098
-1.5%
0.04%
-12.5%
Q4 2019$859,000
-6.6%
102,635
+1.0%
0.04%
-21.6%
Q3 2019$920,000
-9.4%
101,619
+7.8%
0.05%
+2.0%
Q2 2019$1,015,000
+9.8%
94,249
-2.7%
0.05%0.0%
Q1 2019$924,000
-22.6%
96,901
-6.8%
0.05%
-41.2%
Q4 2018$1,194,000
-50.8%
104,017
-27.4%
0.08%
-35.6%
Q3 2018$2,428,000
+21.0%
143,267
+1.4%
0.13%
+9.1%
Q2 2018$2,007,000
-18.3%
141,348
+9.3%
0.12%
-31.6%
Q1 2018$2,458,000
-3.8%
129,355
-16.9%
0.18%
-11.9%
Q4 2017$2,554,000
-63.4%
155,704
-66.5%
0.20%
-65.5%
Q3 2017$6,976,000
+12.2%
465,090
-34.2%
0.58%
+1.6%
Q2 2017$6,220,000
+15.8%
706,859
-31.6%
0.57%
+6.3%
Q1 2017$5,371,000
+638.8%
1,032,859
+333.3%
0.54%
+2056.0%
Q4 2016$727,000
-51.4%
238,351
+149.8%
0.02%
-41.9%
Q1 2015$1,496,00095,4000.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders